- 3101. Iodoxamic Acid
- (UMLS (NCI) C0063803) =Organic Chemical; Pharmacologic Substance ;
| - 3151. IPROCLOZIDE
- (UMLS (NCI) C0063841) =Organic Chemical; Pharmacologic Substance ;
|
- 3102. Ioglicic Acid
- (UMLS (NCI) C0063806) =Organic Chemical
| - 3152. iproniazid
- [An irreversible inhibitor of monoamine oxidase types A and B that is used as an antidepressive agent. It has also been used as an antitubercular agent, but its use is limited by its toxicity. ( MSH )] (UMLS (CSP) C0022059) =Organic Chemical; Pharmacologic Substance
|
- 3103. ioglycamate
- [ ] (UMLS (CSP) C0598550) =Organic Chemical
| - 3153. ipsilateral
- [Having to do with the same side of the body. ( NCI )] (UMLS (NCI) C0441989) =Spatial Concept
|
- 3104. IOGLYCAMIC ACID
- [A radiopaque medium. It is a mixture of its meglumine and sodium salts and is used to visualize the biliary tract. ( MSH )] (UMLS (NCI) C0022003) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 3154. Ipstyl
- (UMLS (NCI) C0920565) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Hormone
|
- 3105. IOHEXOL
- [An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality. ( MSH )] (UMLS (NCI) C0022005) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Triiodobenzoic Acids;
[DX101] NON-IONIC CONTRAST MEDIA =IOPROMIDE;
Ioxilan;
IOHEXOL 755 MG/ML;
Iohexol 388 MG/ML;
IOHEXOL 517.7 MG/ML;
Iohexol 647 MG/ML;
IOHEXOL 302 MG/ML;
IOHEXOL 435 MG/ML;
| - 3155. IPV
- [poliovirus vaccine, inactivated ( HL7V3.0 )] (UMLS (HL7) C0718003) POLIOVIRUS VACCINE INACTIVATED;
POLIOVIRUS VACCINE INACTIVATED PREPARATION;
Poliovirus Vaccine, Inactivated;
=Pharmacologic Substance; Immunologic Factor ;
=poliomyelitis vaccine;
Vaccines administered (code = CVX)(parenteral, unless oral is noted);
VaccineType;
=POLIOVIRUS VACCINE INACTIVATED INJ;
|
- 3106. Iolidonic Acid
- (UMLS (NCI) C0601034) =Organic Chemical; Pharmacologic Substance ;
| - 3156. IQ
- [ ] (UMLS (CSP) C0456149) =Organism Attribute
|
- 3107. Iomeglamic Acid
- (UMLS (NCI) C0063809) =Organic Chemical; Pharmacologic Substance ;
| - 3157. IQ
- [A country in the Middle East, bordering the Persian Gulf, between Iran and Kuwait. (NCI) ( NCI )] (UMLS (NCI) C0022066) =Geographic Area ;
|
- 3108. ion
- [atom or radical having an electrical charge owing to the loss or gain of one or more electrons; substances that form ions are called electrolytes. ( CSP )] (UMLS (CSP) C0022023) =Element, Ion, or Isotope ;
=electrolyte;
Chemical =anion;
cation;
electrolyte;
H+ element;
Chloride;
CALCIUM ION;
carbon ion;
magnesium ion;
polyion;
K+ element;
Na+ element;
F- element;
anion | - 3158. Iqurmuit Traditional Council (formerly Native Vill
- (UMLS (HL7) C1550878) =Population Group =NativeEntityAlaska;
|
- 3109. ION
- [Administration by means of an electric current where ions of soluble salts migrate into the tissues of the body. (FDA) ( NCI )] (UMLS (NCI) C0022024) =Therapeutic or Preventive Procedure ;
| - 3159. IR
- [A country in the Middle East, bordering the Gulf of Oman, the Persian Gulf, and the Caspian Sea, between Iraq and Pakistan. (NCI) ( NCI )] (UMLS (NCI) C0022065) =Geographic Area ;
|
- 3110. Ion Channel
- [molecule-sized pores in biomembranes that permit the passage of hydrophilic solutes such as inorganic ions, and the proteins that form such pores and control their permeability. ( CSP )] (UMLS (NCI) C0022009) =Amino Acid, Peptide, or Protein; Biologically Active Substance =membrane transport protein;
=calcium channel;
potassium channel;
nicotinic receptor;
sodium channel;
chloride channel;
hydrogen channel;
voltage gated channel;
aquaporin;
| - 3160. Ir element
- [metallic element with the atomic symbol Ir, atomic number 77, and atomic weight 192.22. ( CSP )] (UMLS (CSP) C0022071) =Element, Ion, or Isotope ;
=heavy metal;
|
- 3111. ion channel blocker
- [agent that selectively inhibits ion flux through its channel. ( CSP )] (UMLS (CSP) C0872051) =Chemical Viewed Functionally ;
=inhibitor/antagonist;
=[CV200] CALCIUM CHANNEL BLOCKERS | - 3161. Irampanel
- (UMLS (NCI) C1174143) =Organic Chemical; ;
|
- 3112. ion channel in biomembrane
- [ ] (UMLS (CSP) C0598839) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 3162. IRBESARTAN
- [antihypertensive; nonpeptide angiotension 1 subtype; angiotension 2 receptor antagonist. ( CSP )] (UMLS (NCI) C0288171) =Organic Chemical; Pharmacologic Substance =antihypertensive agent;
biphenyl compound;
Tetrazoles;
[CV805] ANGIOTENSIN II INHIBITORS =IRBESARTAN 150 MG;
IRBESARTAN 300 MG;
IRBESARTAN 75 MG;
|
- 3113. Ion Channel Protein
- [Ion Channel Proteins typically aggregate in membrane-associated complexes forming pores whose activities regulate the movement of ions through cellular membranes to affect cellular homeostatic conditions and/or signaling processes. (NCI) ( NCI )] (UMLS (NCI) C1334283) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 3163. IRF1 protein
- [ ] (UMLS (CSP) C0599576) =Amino Acid, Peptide, or Protein ;
|
- 3114. Ion Channel Protein Gene
- [Ion Channel Protein Genes encode Ion Channel Proteins that typically aggregate in membrane-associated complexes forming pores whose activities regulate the movement of ions through cellular membranes to affect cellular homeostatic conditions and/or signaling processes. (NCI) ( NCI )] (UMLS (NCI) C1334284) =Gene or Genome ;
| - 3164. Irgasan
- (UMLS (NCI) C0123928) =Organic Chemical; Pharmacologic Substance ;
|
- 3115. ion cyclotron resonance spectrometry
- [mass spectrometry in which the mass distribution of orbiting ions within a magnetic field is detected by bringing ion frequencies sequentially into resonance with applied radio frequencies. ( CSP )] (UMLS (CSP) C0596799) =Laboratory Procedure =Mass Spec;
| - 3165. IRIDECTOMY NEC
- [ ] (UMLS (ICD9CM) C0176222) =Therapeutic or Preventive Procedure
|
- 3116. ion exchange chromatography
- [separation technique in which the stationary phase consists of ion exchange resins; the resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. ( CSP )] (UMLS (CSP) C0008564) =Laboratory Procedure =chromatography;
| - 3166. Iridencleisis and iridotasis
- [ ] (UMLS (ICD9CM) C0197621) =Therapeutic or Preventive Procedure
|
- 3117. Ion selective electrode (ISE)
- [Electrochemical, Ion Selective Electrode ( HL7V3.0 )] (UMLS (HL7) C0201747) =Laboratory Procedure =ObservationMethod;
| - 3167. iridocyclitis
- [acute or chronic inflammation of the iris and ciliary body characterized by exudates into the anterior chamber, discoloration of the iris, and constricted, sluggish pupil; symptoms include radiating pain, photophobia, lacrimation, and interference with vision. ( CSP )] (UMLS (CSP) C0022073) =Disease or Syndrome ;
=Iris Diseases;
uveitis;
anterior uveitis;
|
- 3118. ion transport
- [movement of ions across cell membranes; can be active, passive or facilitated; ions may travel by themselves (uniport), or as a group of two or more ions in the same (symport) or opposite (antiport) directions. ( CSP )] (UMLS (CSP) C0162585) =Cell Function ;
=biological transport;
=ionophore | - 3168. IRIDODIALYSIS
- (UMLS (ICD9CM) C0152246) =Disease or Syndrome ;
|
- 3119. ionamine
- [ ] (UMLS (CSP) C0022016) =Organic Chemical; Pharmacologic Substance
| - 3169. Iridoplasty and coreoplasty
- [ ] (UMLS (ICD9CM) C0176224) =Therapeutic or Preventive Procedure
|
- 3120. Ione Band of Miwok Indians of California
- (UMLS (HL7) C1554328) =Population Group =NativeEntityContiguous;
| - 3170. IRIDOPLASTY NEC
- [ ] (UMLS (ICD9CM) C0176226) =Therapeutic or Preventive Procedure
|
- 3121. ionic balance
- [ ] (UMLS (CSP) C0598358) =Organism Function ;
| - 3171. IRIDOSCHISIS
- [ ] (UMLS (ICD9CM) C0154919) =Disease or Syndrome
|
- 3122. ionic bond
- [attractive force that draws electrons from one atom to another. ( CSP )] (UMLS (CSP) C0596800) =Natural Phenomenon or Process =chemical bond;
| - 3172. Iridotomy and simple iridectomy
- [ ] (UMLS (ICD9CM) C0176220) =Therapeutic or Preventive Procedure
|
- 3123. ionic strength
- [measure of the level of electrical force in an electrolytic solution. ( CSP )] (UMLS (NCI) C0086486) =Quantitative Concept =Chemical Properties;
| - 3173. IRIDOTOMY NEC
- [ ] (UMLS (ICD9CM) C0176221) =Therapeutic or Preventive Procedure
|
- 3124. ionization
- [Any process by which a neutral atom gains or loses electrons, thus acquiring a net charge, as the dissociation of a substance in solution into ions or ion production by the passage of radioactive particles. ( NCI )] (UMLS (CSP) C0596801) =Phenomenon or Process =chemical reaction;
| - 3174. IRIDOTOMY W TRANSFIXION
- [ ] (UMLS (ICD9CM) C0197499) =Therapeutic or Preventive Procedure
|
- 3125. ionization constant
- [fixed quantity that is based on the ratio of the ions produced from a given substance to the undissociated molecules of the substance. ( CSP )] (UMLS (CSP) C0596802) =Quantitative Concept =Chemical Properties;
| - 3175. Irinotecan Hydrochloride
- [The hydrochloride salt of a semisynthetic derivative of camptothecin, a cytotoxic, quinoline-based alkaloid extracted from the Asian tree Camptotheca acuminata. Irinotecan, a prodrug, is converted to a biologically active metabolite 7-ethyl-10-hydroxy-camptothecin (SN-38) by a carboxylesterase-converting enzyme. One thousand-fold more potent than its parent compound irinotecan, SN-38 inhibits topoisomerase I activity by stabilizing the cleavable complex between topoisomerase I and DNA, resulting in DNA breaks that inhibit DNA replication and trigger apoptotic cell death. Because ongoing DNA synthesis is necessary for irinotecan to exert its cytotoxic effects, it is classified as an S-phase-specific agent. ( NCI )] (UMLS (NCI) C0594375) =Organic Chemical; Pharmacologic Substance ;
=(+)-(4S)-4,11-diethyl-4-hydroxy-9-[(4-piperidino-piperidino)carbonyloxy]-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinol-3,14,(4H,12H)-dione;
=IRINOTECAN HYDROCHLORIDE 20 MG/ML;
|
- 3126. ionizing radiation
- [radiation with sufficient quantal energy to cleave covalent bonds in biomolecules, resulting in ion pair products. ( CSP )] (UMLS (CSP) C0034538) =Natural Phenomenon or Process =radiation;
=Gamma Radiation;
Radiation, X-Rays;
high energy particle;
| - 3176. Irinotecan/Oblimersen
- (UMLS (NCI) C0879423) =Therapeutic or Preventive Procedure
|
- 3127. Ionizing Radiation-Related Malignant Neoplasm
- (UMLS (NCI) C1334285) =Neoplastic Process ;
| - 3177. Irinotecan/Octreotide
- (UMLS (NCI) C0935666) =Therapeutic or Preventive Procedure
|
- 3128. ionomycin
- [a polyether ionophore. ( CSP )] (UMLS (NCI) C0022020) =Lipid; Pharmacologic Substance =Antibiotics;
ionophore | - 3178. Irinotecan/SU5416
- (UMLS (NCI) C0879519) =Therapeutic or Preventive Procedure ;
|
- 3129. ionophore
- [molecule that allows ions to cross lipid bilayers; there are two classes: carriers and channels; carriers, like valinomycin, form cage like structures around specific ions, diffusing freely through the hydrophobic regions of the bilayer; channels, like gramicidin, form continuous aqueous pores through the bilayer, allowing ions to diffuse through. ( CSP )] (UMLS (CSP) C0022022) =Pharmacologic Substance ;
=ion transport;
=ionomycin;
monensin;
| - 3179. Irinotecan/Temozolomide
- (UMLS (NCI) C0879547) =Therapeutic or Preventive Procedure ;
|
- 3130. iontherapy
- [therapeutic introduction of ions of soluble salts into tissues by means of electric current; a form of electro-osmosis; also, a process of increasing the penetration of drugs into surface tissues by the application of electric current. ( CSP )] (UMLS (CSP) C1537073) iontophoresis therapy;
=Therapeutic or Preventive Procedure ;
=body fluid balance therapy;
| - 3180. Irinotecan/Thalidomide
- (UMLS (NCI) C1134668) =Therapeutic or Preventive Procedure
|
- 3131. IontophoresisRoute
- [Iontophoresis ( HL7V3.0 )] (UMLS (HL7) C1700702) =Functional Concept ;
=RouteByMethod;
=Topical application, iontophoresis;
| - 3181. Irinotecan/Trastuzumab
- (UMLS (NCI) C0879275) =Therapeutic or Preventive Procedure
|
- 3132. IOPANOIC ACID
- [Radiopaque medium used as diagnostic aid. ( MSH )] (UMLS (NCI) C0022028) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Iodobenzenes;
[DX102] IONIC CONTRAST MEDIA =IOPANOIC ACID 500 MG | - 3182. Irinotecan/UCN-01
- (UMLS (NCI) C1134582) =Therapeutic or Preventive Procedure ;
|
- 3133. IOPROMIDE
- [A contrast medium. ( NCI )] (UMLS (NCI) C0063817) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=IOHEXOL;
[DX101] NON-IONIC CONTRAST MEDIA =IOPROMIDE 240 MG/ML;
IOPROMIDE 150 MG/ML;
IOPROMIDE 300 MG/ML;
IOPROMIDE 370 MG/ML;
| - 3183. Irinotecan/Vincristine
- (UMLS (NCI) C0796694) =Therapeutic or Preventive Procedure ;
|
- 3134. Iosumetic Acid
- (UMLS (NCI) C0605534) =Organic Chemical; Pharmacologic Substance
| - 3184. iris
- [most anterior portion of the uveal layer, separating the anterior chamber from the posterior; consists of two layers, the stroma and the pigmented epithelium; color of the iris depends on the amount of melanin in the stroma on reflection from the pigmented epithelium. ( CSP )] (UMLS (CSP) C0022077) =Body Part, Organ, or Organ Component ;
=Iris, Ciliary Body and Choroid;
=pupil |
- 3135. IOTHALAMIC ACID
- [An ionic triiodinated benzoate used as a contrast agent in diagnostic imaging. Like other organic iodine compounds, iothalamic acid blocks x-ray and appears opaque on x-ray film, thereby enhancing the visibility of structure and organs during angiography, arteriography, arthrography, cholangiography and computed tomography (CT) scanning procedures. ( NCI )] (UMLS (NCI) C0022034) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid
| - 3185. IRIS ATROPHY NEC
- [ ] (UMLS (ICD9CM) C0154925) =Disease or Syndrome ;
|
- 3136. IOVERSOL
- (UMLS (NCI) C0063828) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=Triiodobenzoic Acids;
[DX101] NON-IONIC CONTRAST MEDIA =IOVERSOL 160 MG/ML;
IOVERSOL 240 MG/ML;
IOVERSOL 300 MG/ML;
IOVERSOL 320 MG/ML;
IOVERSOL 350 MG/ML | - 3186. Iris Malignant Melanoma
- (UMLS (NCI) C0346373) =Neoplastic Process
|
- 3137. Iowa Tribe of Kansas and Nebraska
- (UMLS (HL7) C1554329) =Population Group =NativeEntityContiguous;
| - 3187. Iris Miotic Cyst
- (UMLS (NCI) C0339346) =Finding
|
- 3138. Iowa Tribe of Oklahoma
- (UMLS (HL7) C1554330) =Population Group =NativeEntityContiguous;
| - 3188. Iris Neoplasm
- [Tumors of the iris characterized by increased pigmentation of melanocytes. Iris nevi are composed of proliferated melanocytes and are associated with neurofibromatosis and malignant melanoma of the choroid and ciliary body. Malignant melanoma of the iris often originates from preexisting nevi. ( MSH )] (UMLS (NCI) C0022079) =Neoplastic Process ;
=Iris Diseases;
Neoplasm of the Uvea |
- 3139. IOXAGLIC ACID
- [A ionic triiodinated benzoate used as a contrast agent in diagnostic imaging. Like other organic iodine compounds, ioxaglic acid blocks x-ray and appears opaque on x-ray film, thereby enhancing the visibility of structure and organs during angiography, arteriography, arthrography, cholangiography, urography and computed tomography (CT) scanning procedures. Ioxaglic acid has low osmolarity and therefore, is associated with few side effects compared to older contrast agents. ( NCI )] (UMLS (NCI) C0022041) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Triiodobenzoic Acids;
=IOXAGLATE | - 3189. Iris Nevus
- (UMLS (NCI) C0346376) =Neoplastic Process
|
- 3140. Ioxilan
- (UMLS (NCI) C0063829) =Organic Chemical; Pharmacologic Substance ;
=IOHEXOL;
[DX101] NON-IONIC CONTRAST MEDIA =IOXILAN 300 mgI/ml;
IOXILAN 350 mgI/ml;
| - 3190. IRIS OPERATION NEC
- [ ] (UMLS (ICD9CM) C0176243) =Therapeutic or Preventive Procedure
|
- 3141. Ioxitalamic Acid
- (UMLS (NCI) C0063830) =Organic Chemical; Pharmacologic Substance ;
| - 3191. Iris Spindle Cell Melanoma
- (UMLS (NCI) C1334287) Spindle Cell Melanoma of Iris;
Spindle Cell Melanoma of the Iris;
=Neoplastic Process ;
|
- 3142. IP 10 protein
- [induced protein of 10 kDa; a member of the chemokine family of proinflammatory cytokines and is secreted from a variety of cells in response to interferon-gamma and lipopolysaccharide stimulation; may participate in the regulation of angiogenesis during tumorigenesis. ( CSP )] (UMLS (CSP) C0056978) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=chemoattractant cytokine;
| - 3192. Iris Vascular Disorder
- (UMLS (NCI) C0854284) =Disease or Syndrome
|
- 3143. IP1/IP2/IP3/IP4/IP5/IP6
- [ ] (UMLS (CSP) C0599808) =Carbohydrate; Biologically Active Substance
| - 3193. Iris, Ciliary Body and Choroid
- [pigmented vascular coat of the eyeball, consisting of choroid, ciliary body, and iris. ( CSP )] (UMLS (NCI) C0042160) =Body Part, Organ, or Organ Component =EYE;
=iris;
uvea ciliary body;
choroid uvea |
- 3144. IPECAC
- [A syrup made from the dried rhizomes of two different species, CEPHAELIS ipecacuanha and C. acuminata. They contain EMETINE, cephaeline, psychotrine and other ISOQUINOLINES. Ipecac syrup is used widely as an emetic acting both locally on the gastric mucosa and centrally on the chemoreceptor trigger zone. ( MSH )] (UMLS (NCI) C0022046) =Organic Chemical; Pharmacologic Substance =alkaloid;
IPECAC;
[AD900] ANTIDOTES/DETERRENTS, OTHER;
=IPECAC FLUIDEXTRACT;
IPECAC ALKALOIDS;
IPECAC;
IPECAC FLUIDEXTRACT;
IPECAC ALKALOIDS;
IPECAC 7 GM/100ML;
| - 3194. IRIS/CILIARY DISORD NEC
- [ ] (UMLS (ICD9CM) C1955769) Other disorders of iris and ciliary body;
=Disease or Syndrome |
- 3145. Ipidacrine
- (UMLS (NCI) C0051691) =Organic Chemical; Pharmacologic Substance
| - 3195. Irish
- [Denotes the inhabitants of Ireland, a person from there, or their descendants elsewhere. ( NCI )] (UMLS (NCI) C0087186) =Population Group ;
=European;
|
- 3146. IPO-B
- [Encoded by human SOD2 Gene (Fe/Mn SOD Family), 222-aa 25-kDa (precursor) Manganese Superoxide Dismutase is a homotetrameric free radical scavenging indophenoloxidase in the mitochondrial matrix that is required for normal cell function. A first line of defense against toxic superoxide radical byproducts of the energy generating oxidative phosphorylation pathway, MnSOD maintains the integrity of mitochondrial respiratory chain enzymes susceptible to inactivation by superoxide. Reactive oxygen species and oxidative stress are implicated in a range of degenerative processes including ALS, ischemic heart disease, Alzheimer disease, Parkinson disease, and aging. Mitochondria are the chief source of reactive oxygen species in the cell. (NCI) ( NCI )] (UMLS (NCI) C0968147) Manangese Superoxide Dismutase;
Manganese Superoxide Dismutase;
Mitochondrial Superoxide Dismutase;
Mitochondrial Superoxide Dismutase 2;
Mn Superoxide Dismutase;
MNSOD;
Superoxide Dismutase 2;
=Amino Acid, Peptide, or Protein; Enzyme ;
| - 3196. Irish Setter
- [The Irish Setter is swift, with an acute sense of smell. It has a feathered, silky coat that comes in shades of chestnut to mahogany, sometimes with splashes of white on the chest and feet. The feet are well covered with hair. The chest is narrow. Height: 24-28 inches (61-71cm.) Weight: 55-75 pounds (25-34 kg.) ( NCI )] (UMLS (NCI) C0324447) =Mammal
|
- 3147. ipodate
- [Ionic monomeric contrast media. Usually the sodium or calcium salts are used for examination of the gall bladder and biliary tract. (From Martindale, The Extra Pharmacopoeia, 30th ed, p704) ( MSH )] (UMLS (CSP) C0022049) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid =Iodobenzenes;
[DX102] IONIC CONTRAST MEDIA =Calcium Ipodate;
IPODATE SODIUM;
Calcium Ipodate;
IPODATE SODIUM;
| - 3197. Irish Terrier
- [The Irish Terrier is a medium-sized, well-proportioned terrier with long whiskers, a bearded muzzle with powerful jaws, and bushy eyebrows. The ears are v-shaped and fold forward. The rough looking wiry outer jacket is lined with a softer undercoat. The coat is solid colored and may be red, golden, or wheaten. Height: about 18 inches (43 cm.) Weight: 25-27 pounds (11-12 kg.) ( NCI )] (UMLS (NCI) C0324383) =Mammal
|
- 3148. IPPB
- (UMLS (HL7) C1549533) =Medical Device =Administration Device;
| - 3198. Irish Water Spaniel
- [The Irish Water Spaniel is the largest of the spaniels with a solid brown (leaning to purple), crisp-textured, and curly coat. The long ears are covered with curls. The outer coat is lined with a dense undercoat, which helps insulate the dog in even the coldest water. Webbed feet assist in swimming. Height: 20-23 inches (51-58 cm.) Weight: 45-65 pounds (20-30 kg.) ( NCI )] (UMLS (NCI) C0324465) =Mammal
|
- 3149. Ipratropium/Albuterol
- [A combination of albuterol and ipratropium with a bronchodilatory effect. Albuterol stimulates beta2-adrenergic receptors in the lungs, thereby activating the enzyme adenylate cyclase that catalyzes the conversion of adenosine triphosphate (ATP) to cyclic-3',5'- adenosine monophosphate (cAMP). This results in the relaxation of bronchial smooth muscle, relieve of bronchospasms, and reduction of inflammatory cell mediator release. Ipratropium is a synthetic quaternary ammonium compound and a competitive muscarinic acetylcholine (Ach) receptor antagonist. This agent inhibits vagally mediated reflexes by antagonizing the action of Ach and consequently, prevents the increase in intracellular cyclic guanosine monophosphate, which is a result of ACh interacting with the muscarinic receptor on bronchial smooth muscle. ( NCI )] (UMLS (NCI) C0717386) =Organic Chemical; Pharmacologic Substance ;
| - 3199. Irish Wolfhound
- [A massive, muscular dog, the Irish Wolfhound is one of the tallest breeds in the world. This gentle giant can reach the The Irish Wolfhound is a massive, muscular dog, and is one of the tallest breeds in the world. It can reach the size of a small pony and has a rough, shaggy coat and wiry bushy eyebrows. Colors include gray, brindle, red, black or white. Gray is the most common color. The paws are large and round, with arched toes and strong, curved nails. Height: 28-35 inches (71-90 cm.) Weight: 90-150 pounds (40-69 kg.) ( NCI )] (UMLS (NCI) C0324382) =Mammal
|
- 3150. Iprivask
- (UMLS (NCI) C1259412) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
| - 3200. iritis
- [inflammation of the iris characterized by circumcorneal injection, aqueous flare, keratotic precipitates, and constricted and sluggish pupil along with discoloration of the iris. ( CSP )] (UMLS (CSP) C0022081) =Disease or Syndrome ;
=Iris Diseases;
uvea disorder;
anterior uveitis;
|
home
